These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29272982)

  • 1. The significance of serum IgG
    Tan L; Guan X; Zeng T; Wu S; Zheng W; Fu H; Long T; Wang Q; Meng Y; Tian Y; Yu J; Chen J; Li H; Cao L
    Scand J Gastroenterol; 2018 Feb; 53(2):206-211. PubMed ID: 29272982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference from bile duct cancer and relationship between bile duct wall thickness and serum IgG/IgG4 levels in IgG4-related sclerosing cholangitis.
    Kuwatani M; Kawakami H; Zen Y; Kawakubo K; Kudo T; Abe Y; Kubo K; Sakamoto N
    Hepatogastroenterology; 2014 Oct; 61(135):1852-6. PubMed ID: 25713877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated intrapancreatic IgG4-related sclerosing cholangitis.
    Nakazawa T; Ikeda Y; Kawaguchi Y; Kitagawa H; Takada H; Takeda Y; Makino I; Makino N; Naitoh I; Tanaka A
    World J Gastroenterol; 2015 Jan; 21(4):1334-43. PubMed ID: 25632210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related sclerosing cholangitis: a Japanese cohort.
    Ohara H; Nakazawa T; Kawa S; Kamisawa T; Shimosegawa T; Uchida K; Hirano K; Nishino T; Hamano H; Kanno A; Notohara K; Hasebe O; Muraki T; Ishida E; Naitoh I; Okazaki K
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1247-51. PubMed ID: 23621484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.
    Moon SH; Kim MH; Lee JK; Baek S; Woo YS; Cho DH; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol; 2017 Apr; 52(4):483-493. PubMed ID: 27470434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of isolated proximal-type immunoglobulin G4-related sclerosing cholangitis.
    Takagi Y; Kubota K; Takayanagi T; Kurita Y; Ishii K; Hasegawa S; Iwasaki A; Sato T; Fujita Y; Kato S; Kagawa K; Watanabe S; Sekino Y; Hosono K; Matsuhashi N; Yamanaka S; Iwao T; Yoshida K; Nakajima A
    Dig Endosc; 2019 Jul; 31(4):422-430. PubMed ID: 30570170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012.
    Ohara H; Okazaki K; Tsubouchi H; Inui K; Kawa S; Kamisawa T; Tazuma S; Uchida K; Hirano K; Yoshida H; Nishino T; Ko SB; Mizuno N; Hamano H; Kanno A; Notohara K; Hasebe O; Nakazawa T; Nakanuma Y; Takikawa H; ; ; ;
    J Hepatobiliary Pancreat Sci; 2012 Sep; 19(5):536-42. PubMed ID: 22717980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative clinical characteristics and natural history of three variants of sclerosing cholangitis: IgG4-related SC, PSC/AIH and PSC alone.
    Lian M; Li B; Xiao X; Yang Y; Jiang P; Yan L; Sun C; Zhang J; Wei Y; Li Y; Chen W; Jiang X; Miao Q; Chen X; Qiu D; Sheng L; Hua J; Tang R; Wang Q; Eric Gershwin M; Ma X
    Autoimmun Rev; 2017 Aug; 16(8):875-882. PubMed ID: 28564616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of IgG4-related sclerosing cholangitis.
    Nakazawa T; Naitoh I; Hayashi K; Miyabe K; Simizu S; Joh T
    World J Gastroenterol; 2013 Nov; 19(43):7661-70. PubMed ID: 24282356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment in steroid trial for IgG4-related sclerosing cholangitis.
    Iwasaki S; Kamisawa T; Koizumi S; Chiba K; Tabata T; Kuruma S; Kishimoto Y; Igarashi Y
    Adv Med Sci; 2015 Sep; 60(2):211-5. PubMed ID: 25863870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive Metastatic Cholangiocarcinoma Associated With IgG4-Related Sclerosing Cholangitis Misdiagnosed as Isolated IgG4-Related Sclerosing Cholangitis: A Case Report and Literature Review.
    Zhang YA; Shen XZ; Zhu JM; Liu TT
    Medicine (Baltimore); 2015 Nov; 94(45):e2052. PubMed ID: 26559312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Paying attention to the diagnosis and treatment of IgG4-related sclerosing cholangitis].
    Li BL; Xiao JC
    Zhonghua Wai Ke Za Zhi; 2019 Jul; 57(7):508-512. PubMed ID: 31269612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG4-related sclerosing cholangitis overlapping with autoimmune hepatitis: Report of a case.
    Li H; Sun L; Brigstock DR; Qi L; Gao R
    Pathol Res Pract; 2017 May; 213(5):565-569. PubMed ID: 28238541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
    Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
    Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic usefulness of precise examinations with intraductal ultrasonography, peroral cholangioscopy and laparoscopy of immunoglobulin G4-related sclerosing cholangitis.
    Horiguchi S; Ikeda F; Shiraha H; Yamamoto N; Sakakihara I; Noma Y; Tsutsumi K; Kato H; Hagihara H; Yasunaka T; Nakamura S; Kobashi H; Kawamoto H; Yamamoto K
    Dig Endosc; 2012 Sep; 24(5):370-3. PubMed ID: 22925292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG4-positive sclerosing cholangitis following autoimmune pancreatitis with deranged CA19.9.
    Ong SL; Garcea G; Puls F; Richards C; Mulcahy K; Grant A; Dennison AR; Berry DP
    Int J Surg Pathol; 2011 Feb; 19(1):84-7. PubMed ID: 18611930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan.
    Tanaka A; Tazuma S; Nakazawa T; Isayama H; Tsuyuguchi T; Inui K; Takikawa H
    J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):217-225. PubMed ID: 28103424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized intrahepatic IgG4-related sclerosing cholangitis (IgG4-SC) as an additional type of IgG4-SC: a systematic analysis of 12 cases.
    Mo Z; Ramen K; Shan Y; Zhou M; Zheng X; Wu X; Yu Z; Ji X; Zhang Q; Zeng Q
    Scand J Gastroenterol; 2018 Mar; 53(3):312-318. PubMed ID: 29313399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG4-associated sclerosing cholangitis masquerading as hilar cholangiocarcinoma.
    Yadav KS; Sali PA; Mansukhani VM; Shah R; Jagannath P
    Indian J Gastroenterol; 2016 Jul; 35(4):315-8. PubMed ID: 27439915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
    Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.